Citadel Advisors LLC 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:58 pm Purchase | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Citadel Advisors LLC | 5,334,112 9.600% | 3,249,845 (+155.92%) | Filing |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Citadel Advisors LLC | 2,084,267 7.800% | -8,221 (-0.39%) | Filing |
| 2023-11-17 4:23 pm Purchase | 2023-11-07 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Citadel Advisors LLC | 2,092,488 8.300% | 2,092,488 (New Position) | Filing |